Tuesday, November 8, 2016

BRIEF-Zosano Pharma announces completion of enrollment in pivotal efficacy trial for M207 for acute migraine

* Zosano pharma announces completion of enrollment in

pivotal efficacy trial for m207 for acute migraine

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)